Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Card: Will Drug Discounts Be Permanent Program Fixture?

Executive Summary

The role of a Medicare prescription drug discount card will be worked out between the House Energy & Commerce and Ways & Means Committees before a single Medicare bill comes to the floor for a vote

You may also be interested in...



Medicare Rx Should Cover Dual-Eligibles, Merck Says; Industry Applauds Bill

Merck wants dual-eligible seniors to be covered by the new Medicare Rx benefit to ensure that they are protected by formulary practice standards included in the bill

Medicare Bills Head To Conference: Senate Earns Broader Bipartisan Support

The Senate Medicare prescription drug bill is heading to conference with greater bipartisan support than its counterpart in the House

Medicare Rx Should Cover Dual-Eligibles, Merck Says; Industry Applauds Bill

Merck wants dual-eligible seniors to be covered by the new Medicare Rx benefit to ensure that they are protected by formulary practice standards included in the bill

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042009

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel